Table 1.
Authors, aims, results.
| First Author | Tot Patients and FUP | Survival | Re-Operation | Recurrent IE |
|---|---|---|---|---|
| David T.E. [7] | 43 patients Mean follow-up 38 ± 29 months |
7 intrahospital deaths (16%) 6 late deaths Actuarial survival 6 years 56 ± 6% |
2 (early IE) | 2 patients early IE 1 patient late IE |
| Nilto C. De Oliveira [12] | 76 patients Mean of 47± 47 months |
8 operative deaths (10%) 18 late deaths (24%) Overall survival 5 years 71 ± 6% 10 years 50% ± 9% |
12 patients Freedom from any re-operation 5 years 83 ± 5% 10 years 73 ± 7% |
7 patients Freedom from IE 5 years 85% ± 5% 10 years 85% ± 5% |
| Su Wan Kim [24] | 30 patients Mean follow-up 50.6 ± 43.5 months |
2 hospital deaths (6.7%) 5 late deaths Survival rate in IE patients 1 year 80.8% 5 year 74.6% (5 late deaths) Survival rate in non-IE patients 1 year 87.5% 5 years 87.5% p-value 0.76 |
3 patients (2 IE, 1 heart transplant) Freedom from REDO in IE patients 1 year 95.5% 5 year 84.8% |
1 patient Freedom from IE in IE patients at 1 year 94.7% 5 years 94.7% |
| Alberto Forteza [15] | 40 patients Mean follow-up was 53 ± 8 months |
Hospital mortality rate 22.2% (5 patients) Survival rate group A 1 year 65.4% 5 year 57.7% 10 year 50% Group B 1 year 92.9% 5 years 85.7% 10 years 78.6% |
5 patients Freedom from re-operation group A 1 year 92.3% 5 year 84.6% 10 year 76.0% Group B 1 year 90.9% 5 years 90.9% 10 years 90.9% |
4 patients |
| Anton Tomšič [22] | 35 patients Median follow-up 29.8 months |
8 early deaths (23%) 5 follow-up deaths Overall survival 1 year: 69.4% 2 years: 65.3% 5 years: 65.3% |
7 patients Freedom from REDO 1 year: 84.6% 2 years: 78.9% 5 years: 51.2% |
2 patients |
| Elgharably H. [10] | 37 patients Mean follow-up 581 ± 729 days |
3 hospital deaths (8%) 2 post-discharge deaths (5%) Overall survival 1 year: 91% 3 years: 82% |
1 for aortic pseudoaneurysm (3%) | 1 patient (3%) |
| Navia J.L. [11] | 138 patients Mean follow-up 41 ± 5.9 months |
28 hospital deaths (20%); 21 Commando (24%), 7 Hemi-Commando (13%) Overall survival 1 year 67% 5 year 48% 10 year 37% Commando survival 1 year 60% 5 year 40% 10 year 35% Hemi-Commando survival 1 year 80% 5 year 64% 10 year 57% No significant difference |
Commando: 19 (38%) Hemi-Commando: 4 (12%) Freedom from REDO Commando 1 year 83% 5 year 63% 8 year 50% Freedom from REDO Hemi-Commando 1 year 87% 5 year 74% 8 year 55% |
Commando: 13 (26%); Hemi-Commando: 4 (12%) Freedom from recurrent IE Commando 1 year 87% 5 years 77% 8 years 70% Freedom from recurrent IE Hemi-Commando 1 year 95% 5 years 82% 8 years 41% No significant difference |
| Davierwala PM [17] | 127 patients Mean follow-up 477.5 ± 799.2 months |
Early deaths (30 days): 36 (28.3%); 90 days 47 (37%) Late deaths (follow-up > 90 days): 13 (10.2%) Survival rates 3 years 45.3 ± 5.1 5 years 41.8 ± 5.8%, |
9 patients (7 IE, 2 miscellaneous) Freedom from REDO 5 years 85.1 ± 5.7% |
7 patients |
| Jiang X [23] | 14 patients Mean follow-up 18.9 ± 12.2 months |
Early deaths (60 days): 1 No deaths at follow-up |
No re-intervention | No IE |
FUP: follow-up; IE: Infective endocarditis.